Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor
Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
Tryp Announces First Patient Dosed in Phase 2a for the Treatment of Fibromyalgia